Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|July 19, 2011
Novel imidazo[1,2-a]pyridine based inhibitors of the IGF-1 receptor tyrosine kinase: optimization of the anilineRichard Ducray, Clifford D Jones, Frederic H Jung, et al.
Journal of Medicinal Chemistry|February 6, 2004
Discovery of a new class of anilinoquinazoline inhibitors with high affinity and specificity for the tyrosine kinase domain of c-SrcPatrick A Plé, Tim P Green, Laurent F Hennequin, et al.
Pharmacology Research & Perspectives|October 31, 2015
Prevention of fostamatinib-induced blood pressure elevation by antihypertensive agentsDave Lengel, Eva Lamm Bergström, Herb Barthlow, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in vitro and in vivoRichard W A Luke, Peter Ballard, David Buttar, et al.
Molecular Cancer Therapeutics|September 12, 2015
AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous SchedulesSylvie M Guichard, Jon Curwen, Teeru Bihani, et al.
Molecular Oncology|April 28, 2009
Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530Tim P Green, Mike Fennell, Robin Whittaker, et al.
Journal of Medicinal Chemistry|January 15, 2019
Tricyclic Indazoles-A Novel Class of Selective Estrogen Receptor Degrader AntagonistsJames S Scott, Andrew Bailey, David Buttar, et al.
Pageof 1